Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome

PURPOSE: Patients with myelodysplastic syndrome (MDS) are at risk of relapse after allogeneic hematopoietic cell transplantation. The utility of ultra-deep genomic testing to predict and the impact of conditioning intensity to prevent MDS relapse are unknown. METHODS: Targeted error-corrected DNA se...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JCO Precis Oncol
Auteurs principaux: Dillon, Laura W., Gui, Gege, Logan, Brent R., Fei, Mingwei, Ghannam, Jack, Li, Yuesheng, Licon, Abel, Alyea, Edwin P., Bashey, Asad, Devine, Steven M., Fernandez, Hugo F., Giralt, Sergio, Hamadani, Mehdi, Howard, Alan, Maziarz, Richard T., Porter, David L., Warlick, Erica D., Pasquini, Marcelo C., Scott, Bart L., Horwitz, Mitchell E., Deeg, H. Joachim, Hourigan, Christopher S.
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2021
Sujets:
ORIGINAL REPORTS
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8140814/
https://ncbi.nlm.nih.gov/pubmed/34036237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.20.00355
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires